Lipocine Inc. has filed a Current Report on Form 8-K with the Securities and Exchange Commission dated October 20, 2026. The filing indicates that the company has updated its corporate presentation materials. According to the document, these updated slides are utilized by the company during meetings with investors, analysts, and other parties.
The filing lists the updated presentation as Exhibit 99.1 to the report. The document also includes the standard cover page for the filing. Lipocine Inc. is registered in Delaware and trades on The NASDAQ Stock Market LLC under the ticker symbol LPCN.
